Avalon GloboCare
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALBT and other ETFs, options, and stocks.About ALBT
Avalon GloboCare Corp. is a clinical-stage biotechnology company, which engages in the development of immune effector cell therapy and laboratory services. It operates through the Real Property Operating and Medical Related Consulting Services segments.
CEOMeng Li
CEOMeng Li
Employees5
Employees5
HeadquartersFreehold, New Jersey
HeadquartersFreehold, New Jersey
Founded2014
Founded2014
Employees5
Employees5
ALBT Key Statistics
Market cap5.78M
Market cap5.78M
Price-Earnings ratio-0.14
Price-Earnings ratio-0.14
Dividend yield—
Dividend yield—
Average volume70.74K
Average volume70.74K
High today$1.48
High today$1.48
Low today$1.34
Low today$1.34
Open price$1.38
Open price$1.38
Volume33.96K
Volume33.96K
52 Week high$11.66
52 Week high$11.66
52 Week low$1.21
52 Week low$1.21
Stock Snapshot
As of today, Avalon GloboCare(ALBT) shares are valued at $1.37. The company's market cap stands at 5.78M, with a P/E ratio of -0.14.
On 2025-12-13, Avalon GloboCare(ALBT) stock moved within a range of $1.34 to $1.48. With shares now at $1.37, the stock is trading +2.2% above its intraday low and -7.4% below the session's peak.
Trading volume for Avalon GloboCare(ALBT) stock has reached 33.96K, versus its average volume of 70.74K.
The stock's 52-week range extends from a low of $1.21 to a high of $11.66.
The stock's 52-week range extends from a low of $1.21 to a high of $11.66.
People also own
Based on the portfolios of people who own ALBT. This list is generated using Robinhood data, and it’s not a recommendation.